- Home
- GTE vs SLS Comparison
GTE vs SLS Comparison
Compare GTE & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- SLS
- Stock Information
- Founded
- GTE 2003
- SLS 2012
- Country
- GTE Canada
- SLS United States
- Employees
- GTE N/A
- SLS N/A
- Industry
- GTE Oil & Gas Production
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- GTE Energy
- SLS Health Care
- Exchange
- GTE Nasdaq
- SLS Nasdaq
- Market Cap
- GTE 162.5M
- SLS 169.6M
- IPO Year
- GTE N/A
- SLS N/A
- Fundamental
- Price
- GTE $4.63
- SLS $1.80
- Analyst Decision
- GTE
- SLS Strong Buy
- Analyst Count
- GTE 0
- SLS 1
- Target Price
- GTE N/A
- SLS $7.00
- AVG Volume (30 Days)
- GTE 280.7K
- SLS 3.7M
- Earning Date
- GTE 07-30-2025
- SLS 08-12-2025
- Dividend Yield
- GTE N/A
- SLS N/A
- EPS Growth
- GTE N/A
- SLS N/A
- EPS
- GTE N/A
- SLS N/A
- Revenue
- GTE $634,805,000.00
- SLS N/A
- Revenue This Year
- GTE $11.42
- SLS N/A
- Revenue Next Year
- GTE N/A
- SLS N/A
- P/E Ratio
- GTE N/A
- SLS N/A
- Revenue Growth
- GTE N/A
- SLS N/A
- 52 Week Low
- GTE $3.34
- SLS $0.77
- 52 Week High
- GTE $9.49
- SLS $2.27
- Technical
- Relative Strength Index (RSI)
- GTE 43.91
- SLS 46.63
- Support Level
- GTE $4.39
- SLS $1.75
- Resistance Level
- GTE $5.01
- SLS $1.96
- Average True Range (ATR)
- GTE 0.13
- SLS 0.13
- MACD
- GTE -0.01
- SLS -0.03
- Stochastic Oscillator
- GTE 39.34
- SLS 11.90
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.